Keyvan Ganz, DPM
Sports Medicine · Atlanta, GANPI 1538104096
Payments from drug & device makers
What this record shows
21 manufacturers reported payments, led by Medical Device Business Services, Inc. at 24.9% of the total. Reporting peaked in 2019 at $1,776 and has fallen 57.7% since, to $751 in 2025.
Across 62 payments — averaging $53.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$823
- Treace Medical Concepts, Inc.$709
- Stryker$608
- Amgen$246
- Johnson & Johnson$232
- Melinta Therapeutics, LLC$152
- plus $538 from 15 others
What the payments were for
- Travel & lodging$1,41143%
- Food & beverage$1,89757%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 6 | $823 |
| Treace Medical Concepts, Inc. | 6 | $709 |
| Stryker(2 entities) | 14 | $608 |
| Amgen | 3 | $246 |
| Johnson & Johnson | 4 | $232 |
| Melinta Therapeutics, LLC | 4 | $152 |
| Medtronic | 1 | $117 |
| Sandoz | 4 | $85 |
| Smith+Nephew | 4 | $71 |
| Zyla Life Sciences, Inc. | 3 | $41 |
| Averitas Pharma Inc. | 2 | $38 |
| Lifenet Health | 1 | $24 |
| Biotronik NRO, Inc. | 1 | $23 |
| Merck | 2 | $22 |
| Nabriva Therapeutics, PLC | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Vertex | 1 | $19 |
| Novum Pharma, LLC | 1 | $17 |
| KCI USA, Inc. | 1 | $14 |
| Tactile Systems Technology Inc | 1 | $14 |
| Zimmer Biomet | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,308 in reported general payments places this provider in the 65th percentile of 168 sports medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 74 | $1,064 |
| Ciclopirox | 17 | $858 |
| Ammonium Lactate | 30 | $574 |
| Diclofenac Sodium | 24 | $566 |
| Terbinafine Hcl | 80 | $453 |
| Duloxetine Hcl | 15 | $346 |
| CiclopiroxCiclopirox Olamine | 13 | $188 |
| Methylprednisolone | 21 | $90 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Atlanta
- John XerogeanesAtlanta$4M
- Spero KarasAtlanta$137K
- Xavier DuraldeAtlanta$77K
- Thomas MyersAtlanta$72K
- Phillip LangerAtlanta$33K
- Richard DanilkowiczAtlanta$32K
- Austin LooneyAtlanta$29K
- James KercherAtlanta$24K
- Kyle HammondAtlanta$18K
- Charles GartenAtlanta$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.